Wells, AU, Behr, J, Costabel, U, Cottin, V, Poletti, V, Richeldi, L, Albera, C, Ancochea, J, Antoniou, KM, Bonella, P, Bouros, D, Bresser, P, Cordier, JF, Crestani, B, Domagala-Kulawik, J, Drent, M, Egan, JJ, Geiser, T, Grunewald, J, Grutters, J
, Gudmundsson, G, Guenther, A, Harari, S, Harrison, NK, Hirani, N, Hodgson, U, Kahler, CM, Keane, MP, Kiter, G, Kneussl, M, Maher, TM, Mogulkoc, N, Muller-Quernheim, J, Neurohr, C, Nunes, H, Parfrey, H, Peros-Golubicic, T, Polychronopoulos, V, Prevot, G, Renzoni, ER, Robalo Cordeiro, C, Saltini, C, Skold, M, Spagnolo, P, Thomeer, M, Tomasseti, S, Valeyre, D, Vancheri, C, Wallaert, B, Wuyts, W & Xaubet, A 2012, '
Hot off the breath: Mortality as a primary end-point in IPF treatment trials: The best is the enemy of the good',
Thorax, vol. 67, no. 11, pp. 938-940.
https://doi.org/10.1136/thoraxjnl-2012-202580